These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 30093032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Micelles modified with a chitosan-derived homing peptide for targeted intracellular delivery of ginsenoside compound K to liver cancer cells.
    Zhang J, Jiang Y, Li Y, Li W, Zhou J, Chen J, Shang Z, Gu Q, Wang W, Shen T, Hu W.
    Carbohydr Polym; 2020 Feb 15; 230():115576. PubMed ID: 31887962
    [Abstract] [Full Text] [Related]

  • 3. Preparation of pH-sensitive carboxymethyl chitosan nanoparticles loaded with ginsenoside Rb1 and evaluation of drug release in vitro.
    An Z, Dong Y, Wang W, Wang J, Wu Z, Wang W, He Y, Bao G.
    Int J Biol Macromol; 2024 May 15; 267(Pt 2):131487. PubMed ID: 38599430
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C, Wang Z, Jiang C, Kong M, Zhou X, Li Y, Cheng X, Chen X.
    Int J Pharm; 2013 Nov 30; 457(1):158-67. PubMed ID: 24029170
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H, Wu M, Zhu L, Tian Y, Wu M, Li Y, Deng L, Jiang W, Shen W, Wang Z, Mei Z, Li P, Ran H, Zhou Z, Ren J.
    Theranostics; 2018 Nov 30; 8(7):1892-1910. PubMed ID: 29556363
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.
    Huang C, Li NM, Gao P, Yang S, Ning Q, Huang W, Li ZP, Ye PJ, Xiang L, He DX, Tan XW, Yu CY.
    Drug Deliv; 2017 Nov 30; 24(1):459-466. PubMed ID: 28219253
    [Abstract] [Full Text] [Related]

  • 13. Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma.
    Bu L, Gan LC, Guo XQ, Chen FZ, Song Q, Qi-Zhao, Gou XJ, Hou SX, Yao Q.
    Int J Pharm; 2013 Aug 16; 452(1-2):355-62. PubMed ID: 23685116
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW, Zhao P, Khan A, Raza F, Raza SM, Sarfraz M, Chen Y, Li M, Yang T, Ma X, Xiang G.
    Int J Nanomedicine; 2019 Aug 16; 14():3753-3771. PubMed ID: 31239661
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M, Nafee N, Saad H, Kazem A.
    Eur J Pharm Biopharm; 2014 Sep 16; 88(1):216-25. PubMed ID: 24813390
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.